about
Case-control cohort study of patients' perceptions of disability in mastocytosisDepression in patients with mastocytosis: prevalence, features and effects of masitinib therapyHuman listeriosis caused by Listeria ivanoviiMolecular identification of black-grain mycetoma agentsOsteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic ReviewInvasive mold infections in solid organ transplant recipientsEstimating the burden of Japanese encephalitis virus and other encephalitides in countries of the mekong regionMast cell sarcoma: new cases and literature reviewVoriconazole versus amphotericin B for primary therapy of invasive aspergillosisLiposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)French Intensive Care Society, International congress - Réanimation 2016Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in CambodiaTen-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in FranceEpidemiology and clinical management of Legionnaires' disease.[Influenza and pregnancy].[Pregnancy: a high risk factor in influenza infection].Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach.Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosisLipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosisCryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortalityCentral nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings.Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D studyPhenotypic and genotypic characteristics of mastocytosis according to the age of onset.Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.Major role for amphotericin B-flucytosine combination in severe cryptococcosis.Phylogenetic and genomic diversity of human bacteremic Escherichia coli strainsThalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.Nocardia pseudobrasiliensis as an emerging cause of opportunistic infection after allogeneic hematopoietic stem cell transplantation.Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in ShanghaiPopulation-based analysis of invasive fungal infections, France, 2001-2010.Cryptococcal meningitis: A neglected NTD?Deep dermatophytosis and inherited CARD9 deficiencyPrimary immunodeficiencies underlying fungal infectionsMolecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection SComparison of albicans vs. non-albicans candidemia in French intensive care units.Unmasking leprosy: an unusual immune reconstitution inflammatory syndrome in a patient infected with human immunodeficiency virus.
P50
Q21092209-B8533BB8-C023-46C1-9DDF-F794AFCC2CB9Q21560915-71C6C0D9-1BC3-40B2-A5B1-7C237C773143Q24608921-43436039-1BBA-40FC-8BF1-ABBC7ABFB2EFQ24669636-AF57C671-9668-4F65-A961-5B46E29564BEQ26774766-39BB129A-D7B8-4586-B0AA-EA4260BC97DEQ26823811-F9080B55-D387-4477-9282-14467F436F63Q27024627-3E63C5CA-EF04-4398-BC55-B954681D2322Q28071802-326198CD-4199-4B27-B625-89B1BBC354D5Q28217179-75FC9E1C-7502-47CC-A9FA-F50561F97E35Q28298468-FED4049E-BC73-4FC0-8701-803C204F7E1EQ28550357-3CE1C8D0-CDF5-48D9-AFC3-9AA77161FEF2Q28748511-C3974090-44D9-40F5-999E-5E7A16FFAABEQ28830278-814CD6B6-DBB7-4346-A0F3-F20246416E2BQ30209590-EB77E5F8-CB36-401D-99E4-7D51B3BE16AAQ30375197-C5481E65-6BA2-49D9-AB8E-54B3AFC170C4Q30385377-7E3C2B83-55ED-420E-ADFD-5A9445D5B91DQ30415411-A0E309DA-E315-4377-A8C5-48E1730C0D12Q30426015-EE375D01-4E6E-468B-92FA-CB8B2F1817E7Q30426041-9253FF16-9E4E-49A2-8223-1E2D0BE3411EQ30433949-811210A6-7C2D-4F4A-854C-DB5121529FF8Q30438524-010987FA-57C0-4105-A0BE-9F21C03B09A4Q30438585-EEE06623-9EF8-47A4-91F4-4004D2C5EA8DQ30441628-AFCE4BE4-096C-4765-B185-B09371509F9AQ33272469-02F36FD2-CE45-4F63-8FCC-BAFB0AB59D37Q33327689-2F36431D-45CF-4FC2-8576-C2CB84FAD138Q33328474-5E5F1C47-CD96-48A5-A130-E78463B13F42Q33358131-94754F97-F584-458F-BCEF-F7D3C321B46AQ33387416-1655CC5D-0F94-441D-BAC1-C15DEB7DDF97Q33406035-09573313-10AE-4415-A26E-63AE091F7D40Q33433126-3D71BD47-14D8-4AB8-A004-868E00178577Q33627405-0523E4C2-7F46-4155-8F58-4C5077F401A0Q33644747-D5C9CE95-16C5-4BB6-8D65-5786259061FFQ33661367-19A982CA-8646-436A-AF0D-D60DB77F56F0Q33816423-CC1799A2-25F6-4B12-8E47-D6CB56DAEF8CQ33852819-2540FD1C-A9EB-4D4B-BFC8-8B4C5DC44B6BQ33855073-3554CF6A-5A1B-4BE2-9651-1424A85D7B22Q33902831-FD0BE43C-BD67-404D-8D29-647FE5596D93Q33909379-B75DA84C-208E-412E-985F-23C807A5DE84Q34026915-DADB2A34-7C47-45FA-A940-1BD8B96C8D0FQ34030166-D15EEE37-33CE-4C83-97EC-9DFA2EE8F449
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Olivier Lortholary
@ast
Olivier Lortholary
@en
Olivier Lortholary
@es
Olivier Lortholary
@nl
Olivier Lortholary
@sl
type
label
Olivier Lortholary
@ast
Olivier Lortholary
@en
Olivier Lortholary
@es
Olivier Lortholary
@nl
Olivier Lortholary
@sl
prefLabel
Olivier Lortholary
@ast
Olivier Lortholary
@en
Olivier Lortholary
@es
Olivier Lortholary
@nl
Olivier Lortholary
@sl
P214
P106
P21
P214
P31
P4124
olivier-lortholary_67608
P569
1962-12-09T00:00:00Z
P735
P7859
viaf-76433208